Ellington Management Group’s Elevance Health ELV Stock Holding History

Ellington Management Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,600	Closed	-$1.04M	–	153
2020 Q1	$1.04M	Buy	+4,600	New	+$1.25M	0.25%	102
2019 Q4	–	Sell	-900	Closed	-$216K	–	582
2019 Q3	$216K	Buy	+900	New	+$247K	0.04%	482
2017 Q3	–	Sell	-3,100	Closed	-$583K	–	686
2017 Q2	$583K	Sell	3,100 -3,600	-54%	-$647K	0.08%	200
2017 Q1	$1.11M	Buy	6,700 +3,800	+131%	+$604K	0.04%	73
2016 Q4	$417K	Buy	+2,900	New	+$388K	0.06%	251
2016 Q3	–	Sell	-2,300	Closed	-$302K	–	648
2016 Q2	$302K	Buy	+2,300	New	+$315K	0.42%	52
2015 Q4	–	Sell	-5,800	Closed	-$812K	–	646
2015 Q3	$812K	Buy	5,800 +2,700	+87%	+$406K	0.23%	114
2015 Q2	$509K	Buy	+3,100	New	+$495K	0.12%	234
2013 Q4	–	Sell	-5,000	Closed	-$418K	–	621
2013 Q3	$418K	Buy	+5,000	New	+$429K	0.08%	389

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Ellington Management Group's ELV Position: Q2 2020 in Review

Ellington Management Group sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 4,600 shares — an estimated $1.04M sold.

Ellington Management Group first reported a position in ELV in Q3 2013 and held it in 9 quarters. The position peaked at $1.11M in Q1 2017. 1,108 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

Ellington Management Group reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 4,600 Elevance Health shares in Q2 2020, an estimated $1.04M.
Ellington Management Group first reported a position in Elevance Health in Q3 2013 and held it in 9 quarters.
Ellington Management Group's Elevance Health position peaked at $1.11M in Q1 2017.
1,108 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.